Prognostic value of hypotensive blood pressure response during single-stage exercise test on long-term outcome in patients with known or suspected peripheral arterial disease

Coronary Artery Disease

Volumn 19, Issue 8, 2008, Pages 603-607

  De Liefde, Inge I ^a   Hoeks, Sanne E ^a   Van Gestel, Yvette R B M ^a   Klein, Jan ^a   Verhagen, Hence J M ^a   Van Domburg, Ron T ^a   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

blocker; Aspirin; Blood pressure; Hypotension; Major adverse cerebrovascular and cardiac events; Mortality; Peripheral arterial disease; Statin

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; STATIN;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; TREADMILL EXERCISE;

ADRENERGIC BETA-ANTAGONISTS; AGED; ASPIRIN; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; EXERCISE TEST; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOTENSION; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; TIME FACTORS;

EID: 56849099813     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e328316e9ed     Document Type: Article

References (22)

1. Comess KA, Fenster PE. Clinical implications of the blood pressure response to exercise. Cardiology 1981; 68:233-244.
2. Gibbons RJ, Hu DC, Clements IP, Mankin HT, Zinsmeister AR, Brown ML. Anatomic and functional significance of a hypotensive response during supine exercise radionuclide ventriculography. Am J Cardiol 1987; 60:1-4.
3. Hakki AH, Munley BM, Hadjimiltiades S, Meissner MD, Iskandrian AS. Determinants of abnormal blood pressure response to exercise in coronary artery disease. Am J Cardiol 1986; 57:71-75.
4. Morris CK, Morrow K, Froelicher VF, Hideg A, Hunter D, Kawaguchi T, et al. Prediction of cardiovascular death by means of clinical and exercise test variables in patients selected for cardiac catheterization. Am Heart J 1993; 125:1717-1726.
5. Prakash M, Myers J, Froelicher VF, Marcus R, Do D, Kalisetti D, et al. Clinical and exercise test predictors of all-cause mortality: results from >6,000 consecutive referred male patients. Chest 2001; 120:1003-1013.
6. Dubach P, Froelicher VF, Klein J, Oakes D, Grover-McKay M, Friis R. Exercise-induced hypotension in a male population. Criteria, causes, and prognosis. Circulation 1988; 78:1380-1387.
7. Levites R, Baker T, Anderson GJ. The significance of hypotension developing during treadmill exercise testing. Am Heart J 1978; 95:747-753.
8. Fleg JL, Lakatta EG. Prevalence and significance of postexercise hypotension in apparently healthy subjects. Am J Cardiol 1986; 57: 1380-1384.
9. Gauss A, Rohm HJ, Schauffeien A, Vogel T, Mohl U, Straehle A, et al. Electrocardiographic exercise stress testing for cardiac risk assessment in patients undergoing noncardiac surgery. Anesthesiology 2001; 94:38-46.
10. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324:71-86.
11. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
12. Aronow WS, Ahn C. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. Am J Cardiol 2001; 87:1284-1286.
13. Heidland UE, Strauer BE. Left ventricular muscle mass and elevated heart rate are associated with coronary plaque disruption. Circulation 2001; 104:1477-1482.
14. Moreno PR, Fuster V. The year in atherothrombosis. J Am Coll Cardiol 2004; 44:2099-2110.
15. Narins CR, Zareba W, Moss AJ, Marder VJ, Ridker PM, Krone RJ, Lichstein E. Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med 2004; 164:440-446.
16. Robless P, Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001; 88:787-800.
17. Yeager MP, Fillinger MP, Hettleman BD, Hartman GS. Perioperative beta-blockade and late cardiac outcomes: a complementary hypothesis. J Cardiothorac Vasc Anesth 2005; 19:237-241.
18. De Liefde II, Hoeks SE, van Gestel YRBM, Bax JJ, Klein J, van Domburg RT, Poldermans D. The usefulness of hypertensive blood pressure response during a single-stage exercise test to predict long-term outcome in patients with peripheral arterial disease. Am J Cardiol (in press) (In Press, Corrected Proof, Available online 9 July 2008, www.AJConline.org).
19. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265-2281.
20. Smith EE, Guyton AC, Manning RD, White RJ. Integrated mechanisms of cardiovascular response and control during exercise in the normal human. Prog Cardiovasc Dis 1976; 18:421-444.
21. Morris SN, Phillips JF, Jordan JW, McHenry PL. Incidence and significance of decreases in systolic blood pressure during graded treadmill exercise testing. Am J Cardiol 1978; 41:221-226.
22. Ehsani AA, Austin MB, Biello D. Impaired left ventricular function during exercise in coronary artery disease and exertional hypotension. Cardiology 1988; 75:24-31.